344 related articles for article (PubMed ID: 17018607)
1. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
[TBL] [Abstract][Full Text] [Related]
2. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
[TBL] [Abstract][Full Text] [Related]
3. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation.
Nagpal ML; Davis J; Lin T
Biochim Biophys Acta; 2006 Sep; 1762(9):811-8. PubMed ID: 16934957
[TBL] [Abstract][Full Text] [Related]
5. Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation.
Nagpal ML; Chen Y; Lin T
J Endocrinol; 2004 Dec; 183(3):585-94. PubMed ID: 15590984
[TBL] [Abstract][Full Text] [Related]
6. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
7. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
Shin SY; Nam JS; Lim Y; Lee YH
J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
[TBL] [Abstract][Full Text] [Related]
8. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
Zhou H; Wu J; Wang T; Zhang X; Liu D
Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
[TBL] [Abstract][Full Text] [Related]
9. Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.
Kim M; Choi HY; Woo JW; Chung YR; Park SY
Sci Rep; 2021 Sep; 11(1):18007. PubMed ID: 34504204
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of
Choi J; Ahn SS; Lim Y; Lee YH; Shin SY
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30177620
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
Xanthou G; Williams TJ; Pease JE
Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
[TBL] [Abstract][Full Text] [Related]
12. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
[TBL] [Abstract][Full Text] [Related]
13. Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping.
Ehlert JE; Addison CA; Burdick MD; Kunkel SL; Strieter RM
J Immunol; 2004 Nov; 173(10):6234-40. PubMed ID: 15528361
[TBL] [Abstract][Full Text] [Related]
14. Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.
Li Y; Reader JC; Ma X; Kundu N; Kochel T; Fulton AM
Breast Cancer Res Treat; 2015 Jan; 149(2):403-15. PubMed ID: 25537642
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.
Trentin L; Agostini C; Facco M; Piazza F; Perin A; Siviero M; Gurrieri C; Galvan S; Adami F; Zambello R; Semenzato G
J Clin Invest; 1999 Jul; 104(1):115-21. PubMed ID: 10393705
[TBL] [Abstract][Full Text] [Related]
16. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
17. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts.
Kouroumalis A; Nibbs RJ; Aptel H; Wright KL; Kolios G; Ward SG
J Immunol; 2005 Oct; 175(8):5403-11. PubMed ID: 16210647
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
[TBL] [Abstract][Full Text] [Related]
19. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival.
Giuliani N; Bonomini S; Romagnani P; Lazzaretti M; Morandi F; Colla S; Tagliaferri S; Lasagni L; Annunziato F; Crugnola M; Rizzoli V
Haematologica; 2006 Nov; 91(11):1489-97. PubMed ID: 17082008
[TBL] [Abstract][Full Text] [Related]
20. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
Berchiche YA; Sakmar TP
Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
